medigraphic.com
Colegio de Medicina Interna de México.

2018, Number 2

<< Back Next >>

Med Int Mex 2018; 34 (2)

Substance use in adolescents: Considerations for medical practice

Tena-Suck A, Castro-Martínez G, Marín-Navarrete R, Gómez-Romero P, de la Fuente-Martín A, Gómez-Martínez R

Language: Spanish
References: 52
Page: 264-277
PDF size: 432.08 Kb.


ABSTRACT

Substance abuse among young adults and teenagers represents a considerable health issue, as substance use can be associated to serious injuries, accidents, disabilities, substance use and other psychiatric disorders, suicidal ideation and suicidal behavior, sexual risk practices, among others. In the last years, this health problem has been increasing significantly. The objective of this article is to present a review of general aspects of substance abuse in adolescents, such as: epidemiology, risk factors, screening, evaluation, diagnosis, some considerations for referral and general hospital treatment. As a result, it was found that several risk factors have been identified, such as individual, family and environmental factors. Also, strategies for early detection, counsel and reference to integrated treatment known as SBIRT (Screnning, Brief Intervention, Reference to Treatment) were identified. Finally, it is concluded that the implementation of SBIRT programs in general hospital are effective to improve the link between general hospital services to specialized programs for the treatment of substance use disorders.


REFERENCES

  1. Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010. Lancet 2013;382(9904):1575-1586. doi:10.1016/ S0140-6736(13)61611-6.

  2. Erskine HE, Mof TE, Copeland WE, Costello EJ, et al. A heavy burden on young minds: the global burden of mental and substance use disorders in children and youth. Psychol Med 2015 May;45(7):1551-63. doi:10.1017/S0033291714002888.

  3. Medina-Mora M, Tapia C, Rascón M, Solache G, Otero B, Lazcano G. Epidemiologic status of drug abuse in Mexico. Bull Pan Am Heal Organ 1990;24(1):1-11.

  4. Medina-Mora ME, et al. Consumo de drogas entre adolescentes: resultados de la Encuesta Nacional de Adicciones, 1998. Salud Púb Méx 2003;45(1):516-525. doi:10.1590/ S0036-36342003000700005.

  5. Villatoro J, Medina-Mora ME, Cravioto P, et al. Uso y abuso de drogas en México: Resultados de la Encuesta Nacional de Adicciones 2002. In: CONADIC, ed. Observatorio Mexicano En Tabaco, Alcohol Y Otras Drogas. México: Secretaría de Salud; 2003;71-84.

  6. Borges G, Medina-Mora ME, Wang PS, Lara C, Berglund P, Walters E. Treatment and adequacy of treatment of mental disorders among respondents to the Mexico National Comorbidity Survey. Am J Psychiatr 2006;163(8):1371-1378. doi:10.1176/appi.ajp.163.8.1371.

  7. Secretaría de Salud, Centro Nacional para la Prevención de las Adicciones, Adicciones CNC, Instituto Nacional de Salud Pública, Instituto Nacional de Psiquiatría. Encuesta Nacional de Adicciones 2011. México: Secretaría de Salud; 2012.

  8. Medina-Mora ME, Real T, Villatoro J, Natera G. Las drogas y la salud pública: ¿hacia dónde vamos? Salud Púb Méx 2013;55(1):67-73. doi:10.1590/S0036- 36342013000100010.

  9. Benjet C, Hernández-Montoya D, Borges G, Méndez E. Youth who neither study nor work: Mental health, education and employment. Salud Púb Méx 2012;54(4).

  10. Benjet C, Medina-Mora ME, Borges G, Zambrano J, Aguilar-Gaxiola S. Youth mental health in a populous city of the developing world: Results from the Mexican Adolescent Mental Health Survey. J Child Psychol Psychiatry 2009;50(4):386-395.

  11. Substance Abuse and Mental Health Services Administration. Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings. 2010;I:1-97. http://www.gmhc.org/files/editor/file/a_ pa_nat_drug_use_survey.pdf. Accessed August 18, 2017.

  12. National Center on Addiction and Substance Abuse at CU. Adolescent Substance Use: America’s #1 Public Health Problem; 2011. http://search.ebscohost.com/login.aspx?dire ct=true&db=eric&AN=ED521379&lang=ja&site=ehost-live.

  13. Medina-Mora ME, Benjet C, Borges G, et al. Diferencias de sexo en la prevalencia y severidad de trastornos psiquiátricos en adolescentes de la Ciudad de México. Salud Ment 2009;32(2):155-163.

  14. Steinberg L. A social neuroscience perspective on adolescent risk-taking. Dev Rev 2008;28(1):78-106. doi:10.1016/j. dr.2007.08.002.

  15. Kelley AE, Schochet T, Landry CF. Risk taking and novelty seeking in adolescence: Introduction to part I. In: Ann N Y Acad Sci Vol 1021; 2004:27-32. doi:10.1196/annals. 1308.003.

  16. American Academy of Pediatrics. Indications for management and referral of patients involved in substance abuse (American Academy of Pediatrics Committee on Substance Abuse). Pediatrics 2000;106:143-148.

  17. Sussman S, Skara S, Ames SL. Substance abuse among adolescents. Subst Use Misuse 2008;43(12/13):1802-1828. doi:10.1016/j.admecli.2006.03.001.

  18. Wang J-C, Kapoor M, Goate AM. The genetics of substance dependence. Annu Rev Genomics Hum Genet 2012;13(143):241-261. doi:10.1146/annurevgenom- 090711-163844.

  19. Uhl GR. Molecular genetics of addiction vulnerability. NeuroRx 2006;3(3):295-301. doi:10.1016/j.nurx.2006.05.006.

  20. Li CY, Mao X, Wei L. Genes and (common) pathways underlying drug addiction. PLoS Comput Biol 2008;4(1):0028- 0034. doi:10.1371/journal.pcbi.0040002.

  21. Hiroi N, Agatsuma S. Genetic susceptibility to substance dependence. Mol Psychiatry 2005;10(4):336-344. doi:10.1038/sj.mp.4001622.

  22. Kendler KS, Chen X, Dick D, et al. Recent advances in the genetic epidemiology and molecular genetics of substance use disorders. Nat Neurosci 2012;15(2):181-189. doi:10.1038/nn.3018.

  23. Spear LP. Adolescent neurodevelopment. J Adolesc Heal 2013;52(2 suppl.2):S7-S13. doi:10.1016/j.jadohealth. 2012.05.006.

  24. Schepis TS, Adinoff B, Rao U. Neurobiological processes in adolescent addictive disorders. Am J Addict 2008;17(1):6- 23. doi:10.1080/10550490701756146.

  25. Squeglia LM, Jacobus J, Tapert SF. The influence of substance use on adolescent brain development. Clin EEG Neurosci 2009;40(1):31-38. doi:10.1177/155005940904000110.

  26. Swendsen J, Conway KP, Degenhardt L, et al. Mental disorders as risk factors for substance use, abuse and dependence: Results from the 10-year follow-up of the National Comorbidity Survey. Addiction 2011;105(6):1117-1128. doi:10.1111/j.1360-0443.2010.02902.x.Mental.

  27. Couwenbergh C, Van Den Brink W, Zwart K, Vreugdenhil C, et al. Comorbid psychopathology in adolescents and young adults treated for substance use disorders: A review. Eur Child Adolesc Psychiat 2006;15(6):319-328. doi:10.1007/ s00787-006-0535-6.

  28. Marín-Navarrete R, Benjet C, Borges G, et al. Comorbilidad de los trastornos por consumo de sustancias con otros trastornos psiquiátricos en Centros Residenciales de Ayuda-Mutua para la Atención de las Adicciones. Salud Ment 2013;36(6):471-479. doi:10.17711/SM.0185- 3325.2013.057.

  29. Allen M, Donohue WA, Griffin A, Ryan D, Turner MMM. Comparing the influence of parents and peers on the choice to use drugs: A meta-analytic summary of the literature. Crim Justice Behav 2003;30(2):163-186. doi:10.1177/0093854802251002.

  30. Cleveland MJ, Feinberg ME, Bontempo DE, Greenberg MT. The role of risk and protective factors in substance use across adolescence. J Adolesc Health 2008;43(2):157-164. doi:10.1016/j.jadohealth.2008.01.015.

  31. Ongel Atar A, Yalcin O, Uygun E, Ciftci Demirci A, Erdogan A. The assessment of family functions, dyadic adjustment, and parental attitude in adolescents with substance use disorder. Noropsikiyatri Ars 2016;53(1):35-41. doi:10.5152/ npa.2015.8750.

  32. Wolraich L. Diagnostic and Statistical Manual for Primary Care (DSM-PC) Child and Adolescent Version: Design, intent, and hopes for the future. J Dev Behav Pediatr 1997;18(3):171.

  33. Knight JR, Sherritt L, Harris SK, Gates EC, Chang G. Validity of brief alcohol screening tests among adolescents: a comparison of the AUDIT, POSIT, CAGE, and CRAFFT. Alcohol Clin Exp Res 2003;27(1):67-73. doi:10.1097/01. ALC.0000046598.59317.3A.

  34. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association 2013. doi:10.1176/appi.books.9780890425596.

  35. Cook RL, Chung T, Kelly TM, Clark DB. Alcohol screening in young persons attending a sexually transmitted disease clinic: Comparison of AUDIT, CRAFFT, and CAGE instruments. J Gen Intern Med 2005;20(1):1-6. doi:10.1111/j.1525- 1497.2005.40052.x.

  36. Levy SJL, Williams JF. Substance use screening, brief intervention, and referral to treatment. Pediatrics 2016;138(1):1-168. doi:10.1542/peds.2016-1211.

  37. Ferrer Bosch N, Martínez Sánchez L, Trenchs Sainza de la Maza V. Utilidad de las técnicas de cribado de tóxicos en orina solicitadas desde el servicio de urgencias de un hospital pediátrico. An Pediatr 2017.

  38. Bohn MJ, Babor TF, Kranzler HR. The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings. J Stud Alcohol 1995;56(4):423-432. doi:10.15288/jsa.1995.56.423.

  39. Committee on Substance Abuse, Con S, Levy SJL, Kokotailo PK, et al. Substance use screening, brief intervention, and referral to treatment for pediatricians. Pediatrics 2011;128(5):e1330-40. doi:10.1542/peds.2011-1754.

  40. Winters KC, Kaminer Y. Screening and assessing adolescent substance use disorders in clinical populations. J Am Acad Child Adolesc Psychiatr 2008;47(7):740-744. doi:10.1097/ CHI.0b013e31817395cf.

  41. Ali R, Awwad E, Babor TF, et al. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): Development, reliability and feasibility. Addiction 2002;97(9):1183- 1194. doi:10.1046/j.1360-0443.2002.00185.x.

  42. Latimer WW, Brien MSO, Mcdouall J, et al. Screening for “substance abuse” among school-based youth in Mexico using the Problem Oriented Screening Instrument (POSIT) for Teenagers. 2004;6084 (August 2017). doi:10.1081/ JA-120028492.

  43. Medina-Mora ME, Carreño S, De La Fuente J. Experience with the alcohol use disorders identification test (AUDIT) in Mexico. Recent Dev Alcohol 1998;14:383-396.

  44. Villalobos-Gallegos L, Marín-Navarrete R, Roncero C, González- Cantú H. Latent class profile of psychiatric symptoms and treatment utilization in a sample of patients with cooccurring disorders. Rev Bras Psiquiatr 2016;(ahead):0-0. doi:10.1590/1516-4446-2016-1972.

  45. Pérez-López A, Villalobos-Gallegos L, Viveros C, Graue-Moreno J, Marín-Navarrete R. Three versions of the Short Alcohol Dependence Data Questionnaire (SADD) in Mexican population: a comparative analysis of psychometric properties and diagnostic accuracy. Subst Use Misuse 2015;38(4):281- 286. doi:10.17711/SM.0185-3325.2015.038.

  46. Tiburcio Sainz M, Rosete-Mohedano MG, Natera G, Martínez N, Carreño S. Validity and reliability of the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) in University Students. Adicciones 2016;28(19-27).

  47. Knight JR, Sherritt L, Shrier LA, et al. Validity of the CRAFFT Substance Abuse Screening Test Among Adolescent Clinic Patients. Arch Pediatr Adolesc Med 2002;156(6):607. doi:10.1001/archpedi.156.6.607.

  48. Rahdert E. Problem oriented screening instrument for teenagers. In: National Institute on Drug Abuse, US Department of Health and Human Services, Alcohol, Drug Abuse and MHA, ed. The Adolescent Assessment Referral System Manual; 1991.

  49. Raistrick D, Dunbar G, Davidson R. Development of a questionnaire to measure alcohol dependence. Br J Addict 1983;78(1):89-95. doi:10.1111/j.1360-0443.1983. tb02484.x.

  50. Secretaría de Salud. Prevención, Detección y Consejería en Adicciones para Adolescentes y Adultos en el Primer Nivel de Atención. 2015. http://www.cenetec.salud.gob. mx/descargas/gpc/CatalogoMaestro/023_GPC_Adicciones1erNivel/ SSA_023_08_EyR.pdf. Accessed August 18, 2017.

  51. National Institute on Drug Abuse. Principles of Drug Addiction Treatment: A Research-Based Guide. (National Institute on Drug Abuse, ed.). Rockville: NIH; 1999.

  52. Marín-Navarrete R, Medina-Mora ME, Tena-Suck A. Addiction care in Mexico: a challenge for non-specialized health professionals. Salud Mental 2016;39(5):241-242. doi:10.1177/1557988314565812.




2020     |     www.medigraphic.com